Though not everything in your possession could exactly be replaced, it is still worth having a means of
financial reimbursement in the event of a major loss.
Proper insurance coverage offers
financial reimbursement in the event of loss or damage to a collection.
Every Personal Property Coverage sets some limits to the classes of property liable for
financial reimbursement in the event of a covered loss in order for the insurer to be able to carry out its financial obligations to the client.
Return of Premium Term Insurance is therefore a convenient financial cushion as the insured or the indicated beneficiary is granted
a financial reimbursement in any case.
Not exact matches
These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA
in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results
in subsequent clinical trials; regulatory submissions may not occur or be submitted
in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction
in payment rate or
reimbursement for the company's products or an increase
in the company's
financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors»
in the company's most recent Annual Report on Form 10 - K and
in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions
in the industries and markets
in which United Technologies and Rockwell Collins operate
in the U.S. and globally and any changes therein, including
financial market conditions, fluctuations
in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand
in construction and
in both the commercial and defense segments of the aerospace industry, levels of air travel,
financial condition of commercial airlines, the impact of weather conditions and natural disasters and the
financial condition of our customers and suppliers; (2) challenges
in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies
in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including
in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including
in connection with the proposed acquisition of Rockwell; (7) delays and disruption
in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes
in political conditions
in the U.S. and other countries
in which United Technologies and Rockwell Collins operate, including the effect of changes
in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates
in the near term and beyond; (16) the effect of changes
in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations
in the U.S. and other countries
in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result
in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including
in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense
reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective
financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted
in their operation of their businesses while the merger agreement is
in effect; (21) risks relating to the value of the United Technologies» shares to be issued
in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
Important factors that could cause our actual results and
financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on For
financial condition to differ materially from those indicated
in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes
in pricing, coverage and
reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described
in the Risk Factors and
in Management's Discussion and Analysis of
Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on For
Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018
financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or
reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes
in its stock price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Certain of the underwriters and their respective affiliates have performed, and may
in the future perform, various investment banking,
financial advisory and other services for us, our affiliates and our officers
in the ordinary course of business, for which they received and may receive customary fees and
reimbursement of expenses.
The HRC has intentionally limited perquisites to executive officers and
in 2010 reduced or eliminated almost all executive perquisite programs, including those providing for relocation - related home purchase expenses and
reimbursements for
financial planning services, automobile allowance, club dues, parking, and home security systems.
An earlier filing might have been a telltale sign about the
financial problems to come: Tesla disclosed that it had begun reimbursing Mr. Musk for his use of his private plane, justifying the cost by saying, «By paying only the variable expenses of Mr. Musk's private airplane, consistent with the
reimbursement policy
in place, we will recognize a cost saving as compared to the customary practice for an initial public offering road show.»
Planned Parenthood and its affiliates received $ 553.7 million
in government grants and
reimbursements, according to its 2014 — 2015
financial report.
CMW received
financial reimbursement for travel expenses and an honorarium from the Danone Institute International for her participation
in the conference.
Best of luck to you
in your
reimbursement endevour, I used to work
in the
financial department of a pediatic hospital, so I completely understand the frustration of dealing with insurance companies.
The city is planning to spend $ 337 million
in the coming fiscal year to shore up the bleak
financial situation for its Health and Hospitals Corporation, which de Blasio said was struggling under the weight of detrimental changes
in federal
reimbursements for Medicaid and health costs.
The Economic
Financial and Crimes Commission has denied a report claiming that the Commission has indicted all the governors of the 36 states of the Federation and the Senate President, Bukola Saraki
in the ongoing investigation of the
reimbursement paid to state governments by the Federal Government for excessive deduction charged to them on account of the Paris Club and other international loans.
Unveiled
in May, the proposed rules state that NIH - funded scientists must fully disclose virtually all
financial ties to industry, including travel
reimbursement, speaking fees, and consulting fees, that might be perceived as compromising research objectivity.
And so is University of Wisconsin System president Ray Cross, despite the fact that the measure could cost the state money
in tuition
reimbursements and grants, and potentially result
in financial losses for UW schools.
Also, you should evaluate the cost of repairs and the amount you stand to gain
in reimbursement,
in order to determine whether filing a claim for home insurance makes the best
financial sense.
Currently, most of the participating employers are
in the technology or student loan industries, but companies within the
financial and health industries have also begun offering
reimbursement benefits as well.
Protect your identity and
financial future with
reimbursement insurance that covers up to $ 1M
in damages from ID Theft.
Cybersecurity breaches may cause disruptions and impact each Fund's business operations, potentially resulting
in financial losses; interference with each Fund's ability to calculate its NAV; impediments to trading; the inability of each Fund, the adviser, and other service providers to transact business; violations of applicable privacy and other laws; regulatory fines, penalties, reputational damage,
reimbursement or other compensation costs, or additional compliance costs; as well as the inadvertent release of confidential information.
You will also receive
reimbursements up to $ 4.00 per single transaction for nationwide ATM withdrawal fees imposed by other
financial institutions and incurred during the Monthly Qualification Cycle
in which you qualified.
The Educators for Maine Loan Program is offered to individuals offers
financial reimbursement for loan debt payment for those
in the education field.
These payments also may be made as an expense
reimbursement in cases where the
financial intermediary provides shareholder services to Fund shareholders.
I understand that should I seek private veterinary care not administered by San Antonio Pets Alive,
financial reimbursements will not be made unless approved by our Medical Director
in advance.
As a branch of the American Veterinary Medical Association, the American Veterinary Medical Foundation's (AVMF) Animal Disaster Relief and
Reimbursement (ADRR) programs provide
financial assistance to veterinarians
in the front lines of disaster struck areas.
United States About Blog Healthcare Finance News is the industry's business newspaper, offering healthcare
financial managers comprehensive news coverage of the unprecedented
financial challenges faced by healthcare providers and payers
in light of skyrocketing healthcare costs, regulatory developments and diminishing
reimbursements.
In practice this means that European game developer studios have to pay more from their own
financial resources before receiving
reimbursement from the Commission.
Consequently, if you are searching to get a personal injury lawyer
in College Park who has the knowledge, assets and working experience that is required to assist you be given the
financial reimbursement you will deserve for lost pay, medical bills
in addition to suffering and pain that is due to you based on the Georgia law then look any further.
Georgia law says you're owed
financial compensation as a result of the lost pay, pain and suffering as well as professional medical costs associated with ones injuries; having said that, as a way to get that which is rightfully your compensation you might need a good personal injury lawyer
in College Park that has the knowledge, expertise together with resources required to make it easier to obtain
financial reimbursement for the healthcare expenditures, diminished salary, and pain and suffering due to you under Georgia law.
These damages are strictly
financial in nature and may include
reimbursement of medical and funeral expenses, as well as the value of lost support, services, guidance, and prospective inheritance from the decedent.
Our personal injury lawyer
in Dekalb County GA has the working experience, know - how, and also strategies necessary to assist you to get economic
reimbursement for the healthcare expenditures, loss
in wages, as well as suffering and pain owed to you according to Georgia law.Our personal injury lawyer
in Dekalb County is knowledgeable and skilled to get you and your family the compensation you are eligible for under Georgia law.And so, if you are searching for a personal injury lawyer
in Dekalb County that has the skills, resources along with working experience that is needed that may help you get the
financial reimbursement you will deserve pertaining to lost wages, hospital bills along with suffering and pain which is owed to you
in accordance with the Georgia law then look any further.Georgia law says that you're to be paid
financial compensation due to the lost wages, suffering and pain as well as medical expenses associated with a person's injury; then again,
in an effort to receive what is actually your compensation you will need a very good personal injury lawyer
in Dekalb County that possesses the ability, knowledge together with assets required to help you to receive
financial compensation for the health - related expenditures, diminished earnings, together with pain and suffering owing to you under Georgia law.
New rules to be introduced by the Payment Systems Regulator will
in future make banks and
financial services liable for payment scams and consequent
reimbursement.
And I also pondered what's appropriate
reimbursement in pro bono cases, where clients have no
financial incentive to settle because they're not paying the bill.
Our personal injury lawyer
in Cobb County GA has the experience, knowledge, as well as means required to make it easier to acquire economic compensation for the professional medical expenses, loss of earnings, and suffering and pain owed to you according to Georgia law.Our personal injury lawyer
in Cobb County has the experience, resources and knowledge required to assist you and your family get the payment you rightly deserve under Georgia law.Thus, if you are searching for a personal injury lawyer
in Cobb County that has the skills, assets and also experience that's required that may help you get the economic
reimbursement you will deserve with regard to lost pay, hospital bills and also suffering and pain that is definitely due to you
in accordance with the Georgia law then you don't need to look any further.Georgia law states that you are supposed to be paid
financial reimbursement because of the lost wages, suffering and pain along with professional medical costs associated with a person's injuries; on the other hand, to be able to get that which is actually your compensation you should use a great personal injury lawyer
in Cobb County that possesses the ability, expertise as well as resources necessary to assist you to receive
financial reimbursement for your health - related expenditures, decrease
in earnings, along with suffering and pain due to you according to Georgia law.
The
financial power imbalance between an accident victim and an insurer places the accident victim at a significant disadvantage which is heightened
in circumstances where even if they incur the expense to obtain appropriate medical records and reports, and are successful, they are not entitled to any
reimbursement for the cost of those records and reports, which can often exceed the amount
in dispute.
Georgia law says that you are to be paid
financial reimbursement because of the lost wages, suffering and pain along with medical expenses associated with a person's injury; on the other hand, to be able to obtain just what is justifiably yours, you may need a great personal injury lawyer
in Dacula that has the ability, knowledge as well as assets essential to help you to obtain said
financial compensation.
Career Enrichment / Scholarship Programs — Company sponsored education courses, a Tuition
Reimbursement Program and
financial assistance to children of Protective employees
in need who wish to pursue a college education
Travel insurance ensures that the traveler will get adequate
reimbursement in the event that they experience unexpected
financial losses during their travels, due to an incident of accident, such as a car accident, lost / stolen property including travel documents, and medical coverage.
Financial reimbursement for trip cancellation, interruption and delay
in situations arising from conditions such as illness or bad weather; and for baggage loss and / or delay.
However, with rising costs of education, inflation affecting the prices of essential items, increase
in the cost of medical and hospitalization expenses, the
financial reimbursement received will not be enough to replace the monthly stream of income required for sustenance.
Term Insurance is a type of life insurance
in which substantial amount of
financial reimbursement to the nominees of the insured incase of unexpected death or accident.
He or she is interested
in making sure
financial reimbursement can be found for the building if it is damaged.
This coverage type
in a renters policy is less expensive, but provides less
financial reimbursement for loss.
If an employee under your company's commercial auto insurance plan is hurt
in an accident while driving or riding
in one of your vehicles for work purposes, workers» compensation will typically be the primary source of
financial reimbursement for that employees» injury - related costs.
Essentially, a policy will offer
financial reimbursement for your property
in the event of a loss.
Accounting Assistant responsibilities include managing expense reports and
reimbursements, entering
financial transactions
in
Pallotta TeamWorks, Los Angeles, CA April 2002 — September 2002 Staff Accountant Generated all month - end
financial reports, i.e. balance sheet, income statement, cash flow, and supporting schedules — fixed assets, FASB 13 and deferred rent;
in addition, performed all bank reconciliations and intercompany billings on a monthly basis Assisted external auditors and controller with year - end audit adjustments Managed A / P process — recorded invoices, processed payments and reconciled vendor accounts Coordinated with finance procurement and other department heads for invoice approvals and ensured proper coding of invoices and expense
reimbursements
• Function as expert
in reimbursement rules and act as advocate for patients on
financial issues, while simultaneously providing customer service.